Last reviewed · How we verify
pregabalin 450 mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
pregabalin 450 mg (pregabalin 450 mg) — Viatris Specialty LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| pregabalin 450 mg TARGET | pregabalin 450 mg | Viatris Specialty LLC | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- pregabalin 450 mg CI watch — RSS
- pregabalin 450 mg CI watch — Atom
- pregabalin 450 mg CI watch — JSON
- pregabalin 450 mg alone — RSS
Cite this brief
Drug Landscape (2026). pregabalin 450 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/pregabalin-450-mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab